Rapt Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Rapt Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Rapt Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Rapt Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.9M | 196k | 24.85 |
| 2023-09-30 | $3.0M | 178k | 16.62 |
| 2023-06-30 | $3.5M | 188k | 18.70 |
| 2023-03-31 | $3.2M | 174k | 18.35 |
| 2022-12-31 | $3.9M | 198k | 19.80 |
| 2022-06-30 | $511k | 28k | 18.27 |
| 2022-03-31 | $1.1M | 51k | 21.98 |
| 2021-12-31 | $1.3M | 36k | 36.74 |
| 2021-09-30 | $981k | 32k | 31.08 |
| 2021-03-31 | $227k | 10k | 22.16 |
| 2020-12-31 | $326k | 17k | 19.74 |
| 2020-06-30 | $2.6M | 88k | 29.02 |